- Home
- FINW vs RXST Comparison
FINW vs RXST Comparison
Compare FINW & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FINW | RXST |
|---|---|---|
| Founded | 1999 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.4M | 232.2M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FINW | RXST |
|---|---|---|
| Price | $13.90 | $6.89 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $9.78 |
| AVG Volume (30 Days) | 26.3K | ★ 973.3K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.51 | N/A |
| EPS | ★ 0.35 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $160.48 | N/A |
| Revenue Next Year | $35.27 | $10.06 |
| P/E Ratio | $39.66 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.82 | $4.48 |
| 52 Week High | $22.49 | $13.22 |
Technical Indicators
Market Signals| Indicator | FINW | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 48.55 | 68.48 |
| Support Level | $13.72 | $5.26 |
| Resistance Level | $14.67 | $7.60 |
| Average True Range (ATR) | 0.48 | 0.37 |
| MACD | 0.01 | 0.09 |
| Stochastic Oscillator | 44.89 | 84.08 |
Price Performance
Historical ComparisonAbout FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and commercial customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.